Karsten Wiebe

Further involvements

• 30/03/2023

  08:45 – 09:00 12 Min. 3 Min.

  • Abstract Talk
  • O 080

  Cotreatment with Influenza inhibitors and recombinant IFNα as a potential strategy to prevent emergence of drug resistance against direct-acting antivirals

   Antiviral therapy and resistance, Innate immunity
• 31/03/2023

  11:15 – 11:30 12 Min. 3 Min.

  • Abstract Talk
  • O 105

  Molecular characterisation of a 2017/18 clinical influenza B/Yamagata isolate reveals improved adaptation to the human lower respiratory tract

   Viral pathogenesis and persistence, Viral replication strategies 1 (RNA viruses)